Top Markets
Coin of the day
MegaPro Biomedical Co., Ltd MegaPro Biomedical Co., Ltd

MegaPro Biomedical Co., Ltd

6827
Kedudukan dalam Saham #28596
MegaPro Biomedical Co., Ltd. operates as a biotechnology enterprise primarily... MegaPro Biomedical Co., Ltd. operates as a biotechnology enterprise primarily focused on pioneering nanodrugs. Its innovative development pipeline includes MPB-1523, an IOP injection currently in Phase II clinical evaluation for addressing hepatocellular carcinoma. Simultaneously, MPB-1514, an iron injection, is also undergoing Phase II clinical trials, targeting iron deficiency anemia. Furthermore, the firm is advancing MPB-1734, an anti-cancer pharmaceutical, which is in preclinical assessment for the treatment of malignant tumors. Established in 2014, this company is headquartered in Zhubei, Taiwan.
Harga Saham
$0.32276013
Disegerakkan terakhir: 2026-08-17
Modal Pasaran
$25.60M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-38.97%
Negara
TW
Perdagangan MegaPro Biomedical Co., Ltd (6827)

Kategori

Nisbah P/B bagi MegaPro Biomedical Co., Ltd (6827)
Nisbah P/B pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini MegaPro Biomedical Co., Ltd, nisbah P/B semasa (TTM) ialah 0. Pada akhir 2026, nisbah P/B syarikat ialah 0.
Sejarah nisbah P/B untuk MegaPro Biomedical Co., Ltd dari 2026 hingga 2026
Nisbah P/B pada akhir setiap tahun
Tahun Nisbah P/B Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/B untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/B Perbezaan Nisbah P/B Negara
6.3419 -
US
3.7087 -
US
6.2413 -
NL
2.5054 -
AU
- -
CH